Logo
  • Investing
  • Stock
  • Economy
  • Latest News
Skip to content
Stock
  • Economy
  • Investing
  • Latest News
  • Stock
#
Categories Stock

Here’s why the Circle stock price may jump by 30% soon

March 19, 2026

Circle stock price continued its strong recovery, soaring to its highest level since October 2025, as investors cheered the recent earnings and

#
Categories Stock

HSBC share price outlook as it eyes another round of layoffs

March 19, 2026

The HSBC share price has slumped and moved into a correction after falling by 12% from its highest point this year. It

#
Categories Stock

Here’s why the DAX Index is on the cusp of a steeper crash soon

March 19, 2026

The DAX Index slumped by over 2% on Thursday and is hovering at its lowest level this year as energy prices surged,

#
Categories Stock

XPeng stock price positions for $25 move before earnings

March 18, 2026

XPeng stock price has rebounded in the past few days, with its US ADR rising from $15.35 on March 3 to the

#
Categories Stock

Planet Labs stock on edge ahead of earnings: will it drop 20%

March 18, 2026

Planet Labs stock is stuck in a bear market after falling by 20% from its highest point this year. PL was trading

#
Categories Stock

EUR/CHF and USD/CHF forecasts ahead of the SNB, FOMC decisions

March 18, 2026

The Swiss franc will be in the spotlight this week, as investors focus on the upcoming Federal Reserve and Swiss National Bank

#
Categories Stock

USD/ZAR forecast as South Africa rebounds ahead of Fed, SARB decisions

March 18, 2026

The South African rand is staging a comeback this week, paring back some of the recent losses that started in February. The

#
Categories Stock

Lloyds share price crawls back ahead of BoE decision: will the gains hold?

March 18, 2026

Lloyds share price rose for three consecutive days as London stocks continued their recovery today. It rose to 97.45p on March 18,

Categories Stock

IAG share price nears death cross as it faces a double whammy

March 17, 2026

IAG share price continued its strong downward trend today, March 18, its fifth consecutive day in the red. It has slumped from

#
Categories Stock

Nebius stock price forecast after the $27 billion Meta Platforms deal

March 17, 2026

Nebius stock price surged by over 14% in extended hours after the company landed a $27 billion deal from Meta Platforms. It

Posts navigation

1 2 3 4 5 6 7

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Trending News

    • Recent Posts
    #

    SCHD ETF has pulled back: is it safe to buy the dip now?

    The Schwab US Dividend Equity ETF (SCHD) has slumped to its lowest level since February 4 this...

    #

    Dow risks crash to $43k as Fear and Greed Index tumbles

    The Dow Jones Index is nearing a correction after falling by 9% from its highest point this year....

    #

    BitMine stock eyes an explosive surge as Ethereum price forms a bullish pattern

    BitMine stock price remains in a deep slumber this month, continuing a trend that started in...

    #

    Tilray stock price has just lost a key support: is a crash to $5 coming?

    Tilray stock price has plummeted and lost crucial support as demand for cannabis companies wanes....

    #

    Hang Seng Index at risk of a crash amid Alibaba, Tencent, Xiaomi woes

    The Hang Seng Index remained in a correction this week after falling by 10% from its highest point...

    #

    Here’s why the Nikkei 225 Index moved into a correction

    The Nikkei 225 Index retreated by over 3% on Friday, mirroring the performance of American...

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Biotech-savvy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 Biotech-savvy.com